0002044524-26-000003.txt : 20260430 0002044524-26-000003.hdr.sgml : 20260430 20260430113525 ACCESSION NUMBER: 0002044524-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 EFFECTIVENESS DATE: 20260430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Esanik Therapeutics, Inc. CENTRAL INDEX KEY: 0002044524 ORGANIZATION NAME: EIN: 474281312 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-582376 FILM NUMBER: 26921613 BUSINESS ADDRESS: STREET 1: 7 RAPPS RUN DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-209-8885 MAIL ADDRESS: STREET 1: 7 RAPPS RUN DRIVE CITY: MALVERN STATE: PA ZIP: 19355 D 1 primary_doc.xml X0708 D LIVE 0002044524 Esanik Therapeutics, Inc. 120 West Main Street Northville MI MICHIGAN 48167 610-725-1500 DELAWARE None None Corporation true John Mel Sorensen 120 West Main Street Suite 300 Northville MI MICHIGAN 48167 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2026-04-06 false true true false 0 375000 200000 175000 false 1 0 0 0 Other than the payment of salaries and other compensation benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Esanik Therapeutics, Inc. /s/ John Mel Sorensen John Mel Sorensen President 2026-04-28